//
rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling
Pulmonary artery denervation for treatment of a patient with pulmonary hypertension secondary to left heart disease
Update on chronic thromboembolic pulmonary hypertension
Medical Therapy for CTEPH: Is There Still Space for More?
Treatment Effects of Pulmonary Artery Denervation for Pulmonary Arterial Hypertension Stratified by REVEAL Risk Score: Results from PADN-CFDA Trial
Right ventricular stroke work correlates with outcomes in pediatric pulmonary arterial hypertension
Reply: Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist?
Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist?